ABSTRACT The heparan sulfate proteoglycans, syndecan-1 and glypican, are low-affinity receptors for fibroblast growth factor 2 (FGF2). Because FGF2 is a potent stimulator of skeletal muscle cell proliferation and a strong inhibitor of differentiation, it is likely that changes in syndecan-1 and glypican expression will affect myogenesis as both, in part, regulate FGF-dependent signaling. In the current study, expression vector constructs containing either syndecan-1 or glypican were transfected into turkey myogenic satellite cells resulting in the overexpression of these genes. The amount of expression of
INTRODUCTION
Skeletal muscle myogenesis is a complex process that involves muscle cell proliferation, migration, adhesion, fusion to form multinucleated myotubes, and further differentiation into muscle fibers (Swartz et al., 1994) . This process is precisely regulated, in part through cellular interactions with the extracellular environment. The extracellular environment or matrix is composed of protein and polysaccharides synthesized by the cells (Scott, 1995) . The extracellular matrix (ECM) is necessary for myogenesis due to its interactions with growth factors and other cell surface receptors. These interactions function by modulating gene expression, cell proliferation, and differentiation.
Proteoglycans are one key component of the ECM and represent a diverse family of glycosylated proteins that contain a core protein with covalently attached glycosam- Salaries and research support to S.G.V. were provided by state and federal funds appropriated to the Ohio Agricultural Research and Development Center, The Ohio State University, and research support from the Cooperative State Research, Education, and Extension Service, US Department of Agriculture under Agreement No. 2003-35206-13696. 2 To whom correspondence should be addressed: velleman.1 @osu.edu. 1020 each of these genes was measured by semiquantitative reverse transcriptase polymerase chain reaction. The satellite cell cultures overexpressing syndecan-1 were unable to fuse to form multinucleated myotubes after differentiation was induced. The syndecan-1-transfected cells maintained a rounded morphology typical of cells during proliferation. In contrast, the satellite cells transfected with glypican formed larger myotubes. These results suggest that both syndecan-1 and glypican play pivotal, but different, roles in both muscle cell proliferation and differentiation.
inoglycans (Hardingham and Fosang, 1992) . Glycosaminoglycan chains attached to the core protein include chondroitin sulfate, dermatan sulfate, keratan sulfate, and heparan sulfate. During muscle formation, proteoglycan expression changes from a matrix containing large chondroitin sulfate-rich proteoglycans to one with a mixture of chondroitin sulfate, dermatan sulfate, and heparan sulfate (Young et al., 1990; Fernandez et al., 1991; Velleman et al., 1999) . This expression pattern is conserved across species, suggesting that different proteoglycans have specific functions during muscle development.
The heparan sulfate proteoglycans are low-affinity receptors for fibroblast growth factor 2 (FGF2). Fibroblast growth factor 2 is a potent stimulator of muscle cell proliferation and a strong inhibitor of differentiation (Dollenmeier et al., 1981) . Heparan sulfate proteoglycans have been shown to regulate FGF2 binding to its high-affinity tyrosine kinase receptors (Rapraeger et al., 1991; Yayon et al., 1991) . Therefore, the modulation of heparan sulfate proteoglycan expression during muscle cell proliferation and differentiation may play a pivotal role in muscle development.
Syndecans and glypicans are the major cell-surface heparan sulfate proteoglycans. Both the syndecans and glypicans have been shown to regulate cellular responsiveness to FGF2 (Steinfeld et al., 1996; Filla et al., 1998) . The syndecan family of proteoglycans is composed of 4 members, syndecan-1 through 4, with all members expressed in skeletal muscle. In vitro studies have shown that syndecan-1, 3, and 4 are downregulated during skeletal muscle differentiation (Larraín et al., 1997; Fuentealba et al., 1999) , and syndecan-2 expression remains constant throughout differentiation (Brandan and Larraín, 1998) . Glypicans 1 to 6 have been identified (David et al., 1990; Stipp et al., 1994; Filmus et al., 1995; Watanabe et al., 1995; Saunders et al., 1996; Veugelers et al., 1997 Veugelers et al., , 1999 PaineSaunders et al., 1999) . Only glypican-1 (glypican) has been reported in skeletal muscle (Karthikeyan et al., 1994; Bernfield et al., 1999) . The exact biological function of these proteoglycans during myogenesis has not been precisely defined. However, it has been hypothesized, based on differences in their in vitro expression in myogenic cell cultures, that syndecan-1 may increase muscle cell proliferation by presenting FGF2 to its receptor, and glypican may sequester FGF2 to permit differentiation to proceed (Brandan and Larraín, 1998) .
In order to further define the roles of syndecan-1 and glypican during muscle proliferation and differentiation, a transfection system was developed in which syndecan-1 and glypican were overexpressed in myogenic turkey pectoralis major satellite cell cultures. Satellite cells are myogenic cells that reside between the basement membrane and plasma membrane of muscle fibers (Mauro, 1961) , and are largely responsible for postnatal muscle growth and regeneration (Moss and LeBlond, 1971) . The in vitro culturing of satellite cells results in distinct periods of cell proliferation and differentiation. Therefore, information regarding how syndecan-1 and glypican affect both satellite cell proliferation and differentiation was ascertained in the current study.
MATERIALS AND METHODS

Syndecan-1 and Glypican Vector Constructs
A full-length mouse syndecan-1 cDNA (Saunders et al., 1989) was subcloned into the Sac I/Hind III sites of Clontech's pEGFP-C1 3 terminal enhanced fluorescent protein vector. The chicken glypican cDNA (Niu et al., 1996) was subcloned into the EcoR I/Xba I sites of Clontech's pEGFP-C1 terminal enhanced fluorescent protein vector.
The mouse syndecan-1 cDNA was subcloned from the pBluescript II KS (+/−) 4 in 1× react 2 buffer 6 in a 50-µL final reaction volume at 37°C for 4 h. The reaction was stopped by the addition of 5 µL of 2 M Tris-HCl (pH 8.0). The syndecan-1 cDNA insert was isolated from a 1.5% low melting agarose gel containing 10 µg of ethidium bromide and run with 1× TAE buffer (40 mM Tris-actetate, 1 mM EDTA, pH 8.0). The isolated 1,155-bp syndecan-1 cDNA insert was purified according to the manufacturer's recommended conditions using the Wizard DNA Clean-Up System.
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The chicken glypican cDNA was isolated from the pBluescript II KS (+/−) vector. The glypican cDNA was removed from the pBluescript II KS (+/−) vector by digestion with 20 U Kpn I 6 and 20 U Not I 5 in 1× react 3 buffer 6 in a 50-µL final reaction volume at 37°C for 4 h. The reaction was stopped by the addition of 5 µL of 2 M TrisHCl (pH 8.0). The glypican cDNA insert was isolated from a 1.5% low melting agarose gel containing 10 µg of ethidium bromide and run with 1× TAE buffer. The cDNA insert was purified according to the manufacturer's recommended conditions using the Wizard DNA Clean-Up System. The glypican cDNA was then used as a template for PCR amplification to add in-frame EcoR I and Xba I 6 sites for subcloning into the pEGFP-C1. The left primer was 5′-AGCTTCGAATTCTATGCTGGTTTTGGATGC-3′, and the right primer was 5′-TGATTATCTAGATTAC-CGCCACAAGTGCTG-3′. The PCR conditions for the glypican amplification were 94°C for 5 min, followed by 3 cycles at 94°C for 5 min, 52°C for 1 min, and 72°C for 1 min and then 37 cycles at 94°C for 30 s, 55°C for 30 s, and 72°C for 45 s with a final extension of 72°C for 10 min. The 534-bp PCR product coded for 177 amino acids of the glypican coding region and was purified with a QIAquick PCR Purification Kit. 7 After purification, the PCR product was digested with 15 U of EcoR I 6 and Xba I 6 for 4 h at 37°C. The reaction was stopped by the addition of 5 µL of 2 M Tris-HCl (pH 8.0).
The syndecan-1 expression vector was constructed by digesting 2.5 µg of the pECFP-C1 plasmid with 15 U of Sac I and 15 U of Hind III. The digestion reaction mixture was incubated at 37°C for 4 h, and the reaction was stopped by the addition of 5 µL of 2 M Tris-HCl (pH 8.0). The glypican expression vector was digested with 15 U of EcoRI and Xba I for 4 h at 37°C; the reaction was stopped by the addition of 5 µL of 2 M Tris-HCl (pH 8.0). The digested pEGFP-C1 vectors for the syndecan-1 and glypican subcloning were dephosphorylated with calf intestinal alkaline phosphatase 6 (CIAP). In brief, 44 µL of digested vector DNA, 1 µL CIAP (2 U/µL), and 5 µL of 10× CIAP buffer (500 mM Tris, pH 9.3, 10 mM MgCl 2 , 1 mM ZnCl 2 , and 10 mM spermidine) were combined and incubated at 37°C for 1 h. The reaction was stopped with 50 µL of CIAP reaction stop solution (10 mM Tris, pH 7.5, 1 mM EDTA, 200 mM NaCl, and 0.5% SDS). The dephosphorylated vector DNA was purified with the Wizard DNA Clean-Up System. After the purification, 100 ng of the restriction enzyme-digested dephosphorylated pEGFP-C1 vector DNA and 200 ng of restrictiondigested syndecan-1 and glypican were combined with the appropriate vector and brought to a final volume of 8 µL in nuclease-free water. The reaction mixture was incubated at 45°C for 5 min, and then cooled on ice for 3 min. To the cooled reaction mixture, 1 U of T4 DNA ligase (3 U/µL) and 1 µL of ligation buffer (300 mM TrisHCl, pH 7.8, 100 mM MgCl 2 , 100 mM dithiothreitol, and 10 mM adenosine triphosphate) were added, and the mixture was incubated overnight at 4°C.
The ligated syndecan-1 and glypican expression vectors were transformed into DH 5α max efficiency competent cells. 6 The transformation was carried out by heat shocking a mixture containing 2 µL of the ligation reaction and 50 µL of the competent cells at 37°C for 30 s and then placing the mixture on ice for 2 min. After being placed on ice for 2 min, 950 µL of Lauria broth (10 g BactoTryptone, 8 5 g Bacto-Yeast extract, 8 and 10 g NaCl per 1,000 mL of distilled H 2 O, pH 7.0) was added to each reaction and then incubated at 37°C for 1 h with vigorous shaking at 225 rpm. After the 1-h growing period, 100 µL of the undiluted transformed cells and 100 µL of a 1:100 dilution of the cell reaction mixture were plated on Lauria-kanamycin plates to select colonies with kanamycin resistance. Plates were made as follows: 10 g of Bactotryptone, 8 5 g of Bacto-yeast extract, 8 10 g of NaCl, pH 7.0, and 15 g Bacto-agar 8 were added to 1,000 mL of distilled H 2 O, after adjusting the pH, the medium was autoclaved. After the medium had cooled sufficiently, and just prior to pouring the plates, 50 µg/mL kanamycin was added. The plates were incubated at 37°C overnight, and colonies were then isolated, expanded by growing in Lauria broth containing 50 µg/mL kanamycin, and checked for the presence of the syndecan-1 and glypican cDNA inserts. The cDNA inserts were then sequenced to verify that no cloning errors had occurred.
Cell Culture, RNA Extraction, and Syndecan-1 and Glypican Transfection Satellite cells were isolated from the pectoralis major of 7-wk-old male F-line turkeys (Velleman et al., 2000) . The satellite cells were grown on 35-mm gelatin-coated plates at a density of 45,000 cells per well in a 37°C 95% air/5% CO 2 incubator. The cells were plated in Dulbecco's Modified Eagle Medium (DMEM) 6 containing 10% chicken serum, 9 5% horse serum, 6 1% antibiotic/antimycotic, 6 and 0.1% gentamicin 6 for 24 h, and then switched to McCoy's 5A 6 medium containing 10% chicken serum, 5% horse serum, 1% antibiotic/antimycotic, and 0.1% gentamicin. When the cells reached 65 to 70% confluency (approximately 96 h), the cultures were transiently transfected with Clontech's pEGFP-C1 C-terminal-enhanced fluorescent protein vector, syndecan-1 in pEGFP- C1, or glypican in pEGFP-C1. The satellite cell cultures were transfected using CLONfectin, 3 with 60 to 70% efficiency, according to manufacturer's recommended conditions except that 8 µg of plasmid and 4 µg of CLONfectin were used. The cell cultures were incubated with the transfection solution for 4 h at 37°C in a 95% air/5% CO 2 incubator. The transfection solution was removed by washing the cultures with 37°C DMEM or PBS (170 mM NaCl, 3 mM KCl, 10 mM Na 2 HPO 4 , and 2 mM KH 2 PO 4 , pH 7.08). The cell cultures were then grown in proliferation medium (McCoy's 5A, 15% chicken serum, 10% horse serum, and 0.1% antibiotic/antimycotic) at 37°C in a 95% air/5% CO 2 incubator. After 24 h the cell cultures were extracted for RNA, or transfected cells were selected with G418 6 at 200 µg/mL based on the method of Blanton et al. (2000) . Total RNA was extracted according to the RNAqueous small-scale phenol-free total RNA isolation kit 10 instruction manual. In addition, total RNA was extracted from 18-and 20-d embryonic pectoralis muscle tissue according to the method described by Liu et al. (2004) to measure the dose response of the semiquantitative PCR assay to different concentrations of total RNA. Liu et al. (2004) showed embryonic d 18 to be maximal for syndecan-1 expression and embryonic d 20 to be maximal for glypican expression. The quality of the extracted total RNA was evaluated by the ratio of absorbencies at 260 and 280 nm. Total RNA with a ratio between 1.8 to 2.0 was used for further expression analysis. The medium was changed every 24 h with G418 added to the medium. The transfected cells were grown in the proliferation medium until 60 to 70% confluency (approximately 48 h). At this time, differentiation was induced by culturing the cells in DMEM containing 3% horse serum, 0.01 mg/mL gelatin, and 1.0 mg/mL BSA until 96 h. Every 24 h for the duration of the assay, the cultures were viewed with an Olympus XI 70 microscope and photographed with an Olympus digital camera system, 11 and the images were analyzed using Image-Pro Plus software. 12 The transfections for syndecan-1 and glypican were repeated and viewed 5 times. No variation in the satellite cell morphological characteristic in response to the syndecan-1 and glypican transfections was noted between the assays.
Semiquantitative Reverse Transcription PCR
The first strand of the cDNA was synthesized using the method supplied with the ThermoScript reverse transcriptase (RT) enzyme. 6 In a thin-walled PCR tube, 5.0 µg of total RNA, 2 µL of 50 µM oligo (dT) primers, 10 and nuclease-free H 2 O in a total volume of 12 µL were mixed, heated at 85°C for 3 min, and then cooled on ice for 1 min. This was followed by the addition of 4 µL of 5× cDNA synthesis buffer (250 mM Tris-acetate, pH 8.4, 375 mM potassium acetate, 40 mM magnesium acetate), 6 1 µL of 0.1M dithiothreitol, 1 µL of RNasin ribonuclease inhibitor (40 U/µL), 5 2 µL of deoxynucleotide mix (10 mM each of dATP, dCTP, dGTP, and dTTP), 9 1 µL of sterile H 2 O, and 1 µL of Thermoscript RT enzyme (15 U/ µL) to a final volume of 20 µL. The RT reaction was performed at 50°C for 60 min, followed by a denaturation at 85°C for 5 min; the RT product was allowed to cool to 4°C for use or stored at −20°C. Five microliters of the RT product was used as the template to amplify the cDNA. For glypican and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), the PCR was performed with 1× PCR reaction buffer (10 mM TrisHCl, pH 9.0, 50 mM KCl, and 0.1% Triton X-100), 1.5 mM MgCl 2 , 200 µM of each deoxynucleotide, 0.90 µM of each primer, and 1.25 IU TaqBead hot start polymerase 5 in a 50-µL final volume. For the syndecan-1 PCR reaction, 0.5 mM MgCl 2 was added to the PCR reaction buffer. The syndecan-1 primers were designed based on the turkey syndecan-1 cDNA sequence (GenBank AF416704) with the turkey sequence in this region having 100% homology to the mouse. The forward primer was 5′-CACTTCTGT-CATCAAAGAGGTTGT-3′, and the reverse primer was 5′-CTGTCCAAAAGGCTCTGAGAAG-3′ resulting in a 195-bp fragment. The glypican primers were developed based on the chicken glypican cDNA sequence (Niu et al., 1996) (GenBank L29089) with the amplified turkey sequence having 94% homology to the chicken. The forward primer was 5′-CGTGCTGTCATGAAGCTGAT-3′, and the reverse primer was 5′-GCTACTGCAGAG-GATTTGGC-3′ resulting in a 380-bp fragment.
The PCR conditions for syndecan-1 were 95°C for 5 min followed by 2 cycles at 95°C for 1 min, 57.5°C for 30 s, and 72°C for 1.0 min and then 34 cycles at 95°C for 30 s, 57.5°C for 30 s, and 72°C for 45 s with a final extension of 72°C for 10 min. The glypican cDNA fragment was amplified at 94°C for 5 min, followed by 2 cycles of 94°C for 5 min, 55.5°C for 1 min, and 72°C for 3 min and then 20 cycles at 94°C for 30 s, 55.5°C for 45 s, and 72°C for 1.5 min with a final extension of 72°C for 10 min. The forward primer for GAPDH was 5′-GAGGGTAGT-GAAGGCTGCTG-3′ and the reverse primer was 5′-CCA-CAACACGGTTGCTGTAT-3′. The PCR conditions for GAPDH were 94°C for 5 min followed by 25 cycles of 94°C for 1 min, 55°C for 1 min, and 72°C for 3 min and then 23 cycles of 94°C for 1 min, 55°C for 1 min, 72°C for 3 min with a final extension of 72°C for 10 min. The GAPDH PCR product was 200 bp. The cycle numbers for the PCR amplifications were maintained in the logarithmic phase for each primer set as described by Liu et al. (2004) . The PCR products were analyzed by electrophoretic separation on a 1% agarose gel containing 10 µg of ethidium bromide and run with 1× TBE buffer (89 mM Tris base, 89 mM boric acid, and 2 mM EDTA, pH 8.0). The gel image was recorded with a Kodak 290 digital camera system and analyzed for optical density with Kodak 1D Image Analysis Software. 13 The syndecan-1 and glypican data were normalized to GAPDH (GenBank U94327). The transfections for syndecan-1 and glypican 13 Eastman Kodak Co., Rochester, NY. were repeated 5 times, and from each assay 2 RT reactions were performed for expression analysis by semiquantitative PCR.
Statistical Analysis
Data were analyzed using the GLM procedure of SAS Institute (1985) to estimate differences in expression of syndecan-1 and glypican to that of the control transfected cells. Differences between means were evaluated using a Student's t-test. Differences were considered significant if P < 0.05.
RESULTS
The quantitation of PCR products amplified from total RNA for syndecan-1 and glypican was verified by reverse transcribing total RNA at concentrations of 1.25, 2.5, and 5 µg. For both syndecan-1 ( Figure 1A ) and glypican (Figure 1B) dose-dependent input of total RNA resulted in a dose-dependent quantitation by PCR. Total RNA was extracted from the transfected satellite cell cultures containing syndecan-1 or glypican, or the plasmid without a gene insert (control). The transfected cells were analyzed for syndecan-1 and glypican expression 24 h after the transfection. Both the syndecan-1-and the glypican-transfected satellite cells had a significant increase in syndecan-1 and glypican expression compared with the controls (Figure 2) .
The pEGFP-C1 plasmid vector used in the transfection studies is a fluorescent protein vector due to the expression of green fluorescent protein. Figures 3A, 3C, 3E , 4A, and 4C show the fluorescent images, and figures 3B, 3D, 3F, 4B, and 4D are the companion bright field images. When the the cultures are treated with the antibiotic G418, only the cells that express the plasmid vector are resistant and will survive. Twenty-four hours after the transfection, the control cells were attached to the plates and elongated ( Figure 3A and B) , the syndecan-1-transfected cells maintained a rounded morphol- ogy ( Figure 3C and D) similar to that at the time of plating, and the glypican-transfected cells were attached to the plates with an elongated structure (Figures 3E and F) . Morphologically, after the cell cultures were changed to the differentiation medium to induce myotube formation through the alignment and fusion of the satellite cells, at 48 h of differentiation the control cells had formed myotubes with a diameter of 11.01 ± 1.45 µm ( Figure 4A and 4B) whereas the glypican-transfected cells had formed myotubes with a diameter of 36.66 ± 16.87 µm ( Figure 4C and 4D) . The syndecan-1-transfected cells remained rounded and after the change to differentiation medium were not able to survive to the 48 h differentiation sampling time.
DISCUSSION
The results from the current study have shown that the overexpression of syndecan-1 and glypican alters myogenesis in turkey satellite cells. Increased syndecan-1 expression resulted in the cells maintaining a rounded single cell morphology throughout both proliferation and differentiation. The cells transfected with syndecan-1 were unable to fuse during differentiation to form multinucleated myotubes. In contrast, the satellite cell cultures overexpressing glypican exhibited increased myotube formation.
Although syndecan-1 and glypican are both heparan sulfate proteoglycans that bind to and regulate FGF2, it is clear from the current data that their biological functions are different. Fibroblast growth factor 2 is a strong stimulator of muscle cell proliferation and an inhibitor of differentiation (Dollenmeier et al., 1981) . Based on the in vitro expression of syndecan-1 and glypican, Brandan and Larraín (1998) hypothesized that syndecan-1 presents FGF2 to its high-affinity cell-surface tyrosine kinase receptors to stimulate proliferation whereas glypican functions by sequestering FGF2 from binding to its receptor, allowing differentiation to proceed. The results from the present study are the first data to lend support to this hypothesis concerning the function of syndecan-1 and glypican in muscle development. If syndecan-1 does have the biological function of binding FGF2 to its receptor, proliferation would be enhanced and differentiation inhibited. The inability of the syndecan-1-transfected satellite cells to form multinucleated myotubes is suggestive of this role for syndecan-1. In contrast, if glypican sequesters FGF2 from associating with its receptor, then based on the fact that FGF2 suppresses differentiation, one would expect an overexpression of glypican to lead to enhanced myotube differentiation, which did occur.
The current data are strongly suggestive that the proteoglycans, syndecan-1 and glypican, play pivotal roles in muscle development regulating proliferation and differentiation. Both proliferation and differentiation are central events in skeletal muscle development and growth. The overexpression of syndecan-1 likely results in enhanced FGF2 signaling which will increase muscle cell proliferation. This will result in more myoblasts being available to contribute to the formation of secondary muscle fibers during embryonic development and lead to faster muscle development associated with the process of muscle growth from hyperplasia. Unlike syndecan-1, the overexpression of glypican will decrease FGF2 signaling and permit myotube formation to take place at an elevated rate. This is particularly important for muscle growth by hypertrophy which occurs postnatally and during muscle regeneration from injury. The larger myotube size in the glypican-transfected satellite cell cultures is likely due to increased satellite cell activation.
Other studies have shown the importance of the ECM proteoglycans in skeletal muscle development. For example, Melo et al. (1996) showed that suppressing proteoglycan sulfation inhibited the formation of multinucleated myotubes. Muscle development also involves an ordered expression of myogenic transcriptional regulatory factors. The muscle myogenic transcriptional regulatory factors belong to the basic helix-loop-helix MyoD family and include MyoD, Myf5, Mrf4, and myogenin (Rudnicki and Jaenisch, 1995) . MyoD expression induces the skeletal muscle differentiation program (Weintraub et al., 1991) . Myf5 has been shown by Rudnicki et al. (1993) to function in a redundant manner with MyoD. Myogenin expression induces the formation of multinucleated myotubes and Mrf4 is expressed after fusion (Braun et al., 1989; Wright et al., 1989; Miner and Wold, 1990; Montarras et al., 1991; Rudnicki and Jaenisch, 1995) . There is some limited, but conflicting, data on the requirement of heparan sulfate proteoglycans for the progression of myogenic regulatory factor expression using chemical inhibitors of proteoglycan sulfation. Studies reported by Osses and Brandan (2002) suggest that the ECM influences muscle differentiation independently from the muscle transcriptional regulatory factors. Proteoglycan synthesis was inhibited by sodium chlorate and β-D-xyloside. Although matrix assembly was altered, the treatments did not alter the expression of the muscle transcriptional regulatory factors. In contrast to the findings of Osses and Brandan (2002) , Cornelison et al. (2001) showed that inhibiting heparan sulfate proteoglycan sulfation delayed myogenic satellite cell proliferation and altered MyoD expression. The addition of exogenous heparin restored MyoD expression, suggestive of the involvement of heparan sulfate proteoglycans in MyoD expression. How the expression of specific ECM heparan sulfate proteoglycans affects the expression of each of the muscle transcriptional regulatory factors has not been investigated to date. Because the overexpression of syndecan-1 does not permit differentiated myotubes to form, it is likely that both Mrf4 and myogenin expression are inhibited or reduced. In contrast, glypican overexpression enhances myotube formation which may lead to elevated Mrf4 and myogenin expression. To further understand the mechanism by which the proteoglycans, syndecan-1 and glypican, regulate both muscle cell proliferation and differentiation, FGF2 signaling and muscle transcriptional regulatory factor expression must be studied in relation to syndecan-1 and glypican expression.
